Share class: EDAP TMS S.A.

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 37,373,312 12,416,360 ( 33.22 %) 269,533 ( 0.7212 %) 33.22 %

Major shareholders: EDAP TMS S.A.

NameEquities%Valuation
Soleus Capital Management LP
19.55 %
7,309,254 19.55 % 32 M $
Morgan Stanley & Co. International Plc
8.965 %
3,352,080 8.965 % 15 M $
Rock Springs Capital Management LP
3.441 %
1,286,500 3.441 % 6 M $
Flax Pond Capital LLC
2.132 %
797,246 2.132 % 3 M $
Bruce & Co., Inc.
1.173 %
438,652 1.173 % 2 M $
UBS Financial Services, Inc.
0.5556 %
207,756 0.5556 % 907 894 $
Parkman Healthcare Partners LLC
0.4141 %
154,832 0.4141 % 676 616 $
Schonfeld Strategic Advisors LLC
0.3706 %
138,580 0.3706 % 605 595 $
Cahill Financial Advisors, Inc.
0.3609 %
134,960 0.3609 % 589 775 $
U.S. Bank Main Branch (363657)
0.3182 %
119,000 0.3182 % 520 030 $
░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
NameEquities%Valuation
3.363 %
1,241,780 3.363 % 5 M $
0.8155 %
301,149 0.8155 % 1 M $
0.7299 %
269,533 0.7299 % 1 M $
0.1124 %
41,490 0.1124 % 181 311 $
0.0677 %
25,000 0.0677 % 109 250 $
0.0138 %
5,100 0.0138 % 22 287 $

Breakdown by shareholder type

Institutional38.67%
Individuals4.5%
EDAP TMS SA0.72%
Other0.41%
Unknown55.7%

Based on 1000 largest holdings

Geographical origin of shareholders

United States
29.83%
United Kingdom
8.96%
Individuals
4.5%
France
0.72%
Switzerland
0.26%
Luxembourg
0.02%

Based on 1000 largest holdings

Logo EDAP TMS S.A.
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Employees
310